Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EN
Enovis Corporation
ENOV
Mkt Cap
$1.13B
Volume
1.03M
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EN
ENOV
EN
Enovis Corporation
ENOV
News
·
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
Mkt Cap
$1.12B
Volume
1.03M
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
Enovis Corporation (NYSE: ENOV) announced it will host an investor conference call on August 6th, 2026 at 8:30 a.m. Eastern Time to discuss its second quarter 2026 financial results. The company will issue an earnings press release that morning, with the live webcast and presentation accessible from its website.
GlobeNewswire Inc. · Jul 17, 2026
4 Top Growth Stocks Worth Buying Under $100 Today
The article highlights four undervalued growth stocks positioned to benefit from long-term secular trends: Enovis (orthopedic implants driven by aging population), Insteel Industries (infrastructure and data center construction), Mueller Water Products (water infrastructure replacement), and Proto Labs (transitioning from prototyping to production manufacturing). All trade under $100 and are recommended for patient, long-term investors.
The Motley Fool · Jul 3, 2026
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?
Front Street Capital Management purchased 384,124 additional shares of Enovis (ENOV) in Q1 2026 for approximately $9.08 million, increasing their stake to 2.25% of fund assets. The purchase signals institutional confidence in the medical device company despite ENOV shares being down 23.99% over the past year. Insider buying activity also suggests bullish sentiment, though the company reported a net loss of $1.14 billion in trailing twelve months.
The Motley Fool · May 23, 2026
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
Enovis Corporation (NYSE: ENOV) announced it will host an investor conference call on May 7th, 2026 at 8:30 a.m. ET to discuss first quarter 2026 financial results. The company reported continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically, with Reconstructive sales growing 10% year-over-year on a reported basis and 8% organically.
GlobeNewswire Inc. · Apr 10, 2026
An Enovis (ENOV) Insider Bets Big on the Stock With a Purchase of 2,468 Shares
John Kleckner, Principal Accounting Officer of Enovis Corporation, purchased 2,468 shares on Nov. 25, 2025, signaling potential confidence in the company despite a challenging year with significant quarterly losses.
The Motley Fool · Dec 8, 2025
Enovis to Participate in Upcoming Investor Conferences
Enovis Corporation will participate in three investor conferences in August and September 2025, including Canaccord Genuity, Wells Fargo Healthcare, and Baird Global Healthcare Conferences.
GlobeNewswire Inc. · Aug 8, 2025
Enovis (ENOV) Q2 Revenue Rises 7%
Medical technology company Enovis reported Q2 2025 revenue of $564.5 million, up 7% year-over-year, beating analyst estimates. The company raised full-year guidance and saw strong performance in its Reconstructive segment, despite ongoing integration and regulatory challenges.
The Motley Fool · Aug 7, 2025
Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor
The orthopedic braces and supports market is projected to grow at a CAGR of 5.04% from 2024 to 2030, driven by the increasing burden of orthopedic conditions, sports-related injuries, and the development of smart and custom-made braces.
GlobeNewswire Inc. · May 26, 2025
Enovis Announces Planned CEO Succession Process
Enovis Corporation announced that CEO Matt Trerotola will retire, and the company is actively searching for his successor. Trerotola will remain as an executive advisor for a year to facilitate a smooth transition.
GlobeNewswire Inc. · Feb 26, 2025
Enovis™ Announces Leadership Change to International Surgical Business
Enovis, a global medical technology company, announced that Davide Visentin will succeed Dr. Benjamin Reinmann as President of Enovis International Surgical, effective March 1, 2025. Visentin is an experienced MedTech executive who previously held leadership roles at BD, Stryker, and Johnson & Johnson Depuy Synthes.
GlobeNewswire Inc. · Jan 17, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
EN
ENOV
Enovis Corporation
Buy
Sell
Market
Limit
Soon
ENOV
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any ENOV yet.
Related Tickers
Earnings